Eva Polverino Back

Eva Polverino has achieved her medical degree in Naples and her specialty and PhD in Respiratory Medicine at the University of Pisa (Italy). After training in research on pathophysiology of respiratory disease she started working in the field of clinical and translational research in respiratory infections. She developed her major experience in this field as post doctoral investigator at Fundació Clinic of Barcelona. She was associated Professor of the Faculty of medicine (University of Barcelona) between 2014 and 2016 and director of 5 doctoral theses and of an end-of-course project of a medical student. Her main lines of investigation currently are: non cystic fibrosis bronchiectasis (NCFBE), cystic fibrosis (CF); immunodeficiencies and respiratory diseases; Community-acquired pneumonia (CAP) and Health-care associated pneumonia (HCAP).

She is particularly active at European level as: 1. Secretary of the European Assembly of respiratory infections (Assembly 10) and member of the “long range planning committee of Assembly 10” of European Respiratory Society ERS). 2. Spanish delegate for the HERMES project (Harmonising education in respiratory medicine for European specialists) in respiratory infections for ERS; 3. Co-chair of the European Registry of Bronchiectasis (EMBARC, www.bronchiectasis.eu) and clinical research collaboration) of ERS. 4. Chair of the European Task force for the guidelines of Bronchiectasis (funded by ERS) 5. Co-investigator of different EU funded projects aimed at investigating new treatments, reduce antibiotic overuse and resistance occurrence control (a. iABC - “Inhaled Antibiotics in Bronchiectasis and Cystic fibrosis”, Innovative Medicine Initiative EU 2014 Consortium EFPIA, co-leader of WP4b; b. “Genomics to combact Resistance against Antibiotics in Community- Acquired LRTI in Europe”; c. “Combating Bacterial Resistance in Europe”; d. “An integrated platform enabling Theranostic applications at the point of primary care”); 6. Principal investigator and collaborator of numerous clinical trials in respiratory infections (new drugs for CAP, CF and NCFBE) and in respiratory physiotherapy. Responsible of the Outpatient Clinics and surveillance service of NCFBE and CAP at Hospital Clinic (Barcelona), she is now working at Hospital Vall D’Hebron in the CF and NCFBE Unit and is senior investigator in respiratory infection at Vall D’Hebron Instuitut de Recerca (VHIR). Member of the Panel for the development of Spanish guidelines of Bronchiectasis and of the Group of respiratory infections of the Spanish Society of Pneumology (Area TIR, SEPAR). Editor for Springer and ERJ monograph, author of > 50 scientific publications, reviewer of >10 scientific journals, and for the Spanish “Agencia Nacional de Evaluación y Prospectiva (ANEP), the candidate is expert in medical writing. Dr Polverino is a frequent speaker and moderator at scientific congresses (ERS, SEPAR, etc.) and seminars/classes regarding infections in respiratory diseases. The candidate has gained particular experience in 1) promoting and leading collaborative research across different countries and centers, 2) in scientific communication and 3) educational activities.

Back